Compound information
- Natural Products
- ZC2330124
- Molecular Formula
- C25H39N3O5
- Molecular Weight
- 461.288971348 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1R)-1-[[(1S)-1-[[(1R)-1-formylbutyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C25H39N3O5/c1-6-10-20(15-29)26-23(30)21(13-17(2)3)27-24(31)22(14-18(4)5)28-25(32)33-16-19-11-8-7-9-12-19/h7-9,11-12,15,17-18,20-22H,6,10,13-14,16H2,1-5H3,(H,26,30)(H,27,31)(H,28,32)/t20-,21+,22-/m1/s1
- InChI Key
- QEJRGURBLQWEOU-BHIFYINESA-N
- SMILES
- CCC[C@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)OCc1ccccc1
- Source
- ZINC000098044152
Warheads
- Carbamate
-
- Aldehydic carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 33 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 14 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 113.6 Å2 | LogP | 4.222 |
LogS | -4.303 | LogD | 4.684 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.992 | Pgp substrate | 0.09 |
HIA | 0.96 | F20 % | 0.991 |
F30 % | 0.808 | Caco-2 | -4.747 |
MDCK | -5.093 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.768 | PPB | 72.22 |
VD | 0.457 | Fu | 1.382 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.007 | CYP1A2 substrate | 0.601 |
CYP2A6 substrate | 0.274 | CYP2B6 substrate | 0.408 |
CYP2C19 inhibitor | 0.782 | CYP2C19 substrate | 0.866 |
CYP2C8 substrate | 0.685 | CYP2C9 inhibitor | 0.264 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.009 |
CYP2D6 substrate | 0.541 | CYP2E1 substrate | 0.304 |
CYP3A4 inhibitor | 0.921 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.859 | CL | 6.642 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.005 | Hepatotoxicity | 0.985 |
Mutagenicity | 0.104 | Rat Oral Acute Toxicity | 0.689 |
FDAMDD | 0.28 | Skin Sensitization | 0.857 |
Carcinogenicity | 0.033 | Eye Corrosion | 0.007 |
Eye Irritation | 0.018 | Respiratory Toxicity | 0.029 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.142 | IGC50 | 3.548 |
LC50FM | 4.226 | LC50DM | 5.034 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.19 | NR-AR-LBD | 0.382 |
NR-AhR | 0.006 | NR-Aromatase | 0.032 |
NR-ER | 0.383 | NR-ER-LBD | 0.345 |
NR-PPAR-gamma | 0.365 | SR-ARE | 0.637 |
SR-ATAD5 | 0.275 | SR-HSE | 0.073 |
SR-MMP | 0.111 | SR-p53 | 0.042 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.